Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

3.6K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.6K
Acne Infection01:27

Acne Infection

94
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
94
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Drug Therapy01:28

Drug Therapy

449
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
449

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dermatologists' Perspectives on Biosimilars.

Journal of drugs in dermatology : JDD·2024
Same author

Academy of Managed Care Pharmacy.

P & T : a peer-reviewed journal for formulary management·2017
Same author

American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting.

P & T : a peer-reviewed journal for formulary management·2017
Same author

Challenges and Solutions in Reducing Opioid Misuse and Abuse.

P & T : a peer-reviewed journal for formulary management·2017
Same author

Covering the Cost of the Cure: From Hepatitis C to Cancer, New Therapies Are Straining a System Plagued by Inefficiency.

P & T : a peer-reviewed journal for formulary management·2016
Same author

American Academy of Ophthalmology 2015 Annual Meeting.

P & T : a peer-reviewed journal for formulary management·2016

Related Experiment Video

Updated: May 4, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.4K

Advances in psoriasis treatment: experts comment on recent developments.

Peter Sonnenreich

    P & T : a Peer-Reviewed Journal for Formulary Management
    |January 7, 2014
    PubMed
    Summary

    This study reviews biologics for safer, more effective psoriatic lesion treatment. It also examines patient adherence challenges to improve therapeutic outcomes.

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • Psoriatic lesions present significant treatment challenges.
    • Biologic therapies offer potential for improved safety and efficacy.
    • Patient nonadherence is a major barrier to effective psoriasis management.

    Purpose of the Study:

    • To review current biologic treatments for psoriatic lesions, focusing on safety and efficacy.
    • To explore strategies for improving patient adherence to psoriasis treatment regimens.

    Main Methods:

    • Literature review of recent studies on biologics for psoriasis.
    • Analysis of factors contributing to nonadherence in dermatological treatments.

    Main Results:

    • Several biologics demonstrate promising safety and efficacy profiles for psoriatic lesions.

    More Related Videos

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
    02:28

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

    Published on: March 1, 2024

    1.1K
    Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells
    04:53

    Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells

    Published on: January 12, 2024

    1.7K

    Related Experiment Videos

    Last Updated: May 4, 2026

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    38.4K
    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
    02:28

    Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

    Published on: March 1, 2024

    1.1K
    Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells
    04:53

    Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells

    Published on: January 12, 2024

    1.7K
  • Nonadherence is multifactorial, influenced by medication cost, side effects, and patient-provider communication.

    • Conclusions:

    • Biologics represent a significant advancement in managing psoriatic lesions.
    • Addressing nonadherence through patient education and tailored support is crucial for optimizing treatment success.